To further confirm the expression of CD38 on TAMs from patients with HCC, tumor-infiltrating leukocytes (TILs) were examined using the DEPArrayTM, which is an automated platform capable of visualizing and isolating single cells with high resolution and purity. The gene discussed is CD38; the disease is hepatocellular carcinoma.